- December 12, 2019
CarthroniX successfully completed its Seed Funding round to support
the diversification of its research portfolio and advancement of the
current IND-enabling studies for Osteoarthritis and Wound healing.
The Series A round is planned for Q3 2020 and will raise funds to
support clinical development of CX-011 for OA.